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Background: In the compact and haploid genome of Dictyostelium discoideum control of transposon activity is of
particular importance to maintain viability. The non-long terminal repeat retrotransposon TRE5-A amplifies
continuously in D. discoideum cells even though it produces considerable amounts of minus-strand (antisense) RNA
in the presence of an active RNA interference machinery. Removal of the host-encoded C-module-binding factor
(CbfA) from D. discoideum cells resulted in a more than 90 % reduction of both plus- and minus-strand RNA of
TRE5-A and a strong decrease of the retrotransposition activity of the cellular TRE5-A population. Transcriptome
analysis revealed an approximately 230-fold overexpression of the gene coding for the Argonaute-like protein AgnC
in a CbfA-depleted mutant.
Results: The D. discoideum genome contains orthologs of RNA-dependent RNA polymerases, Dicer-like proteins,
and Argonaute proteins that are supposed to represent RNA interference pathways. We analyzed available mutants
in these genes for altered expression of TRE5-A. We found that the retrotransposon was overexpressed in mutants
lacking the Argonaute proteins AgnC and AgnE. Because the agnC gene is barely expressed in wild-type cells,
probably due to repression by CbfA, we employed a new method of promoter-swapping to overexpress agnC in a
CbfA-independent manner. In these strains we established an in vivo retrotransposition assay that determines the
retrotransposition frequency of the cellular TRE5-A population. We observed that both the TRE5-A steady-state RNA
level and retrotransposition rate dropped to less than 10 % of wild-type in the agnC overexpressor strains.
Conclusions: The data suggest that TRE5-A amplification is controlled by a distinct pathway of the Dictyostelium
RNA interference machinery that does not require RNA-dependent RNA polymerases but involves AgnC. This
control is at least partially overcome by the activity of CbfA, a factor derived from the retrotransposon’s host. This
unusual regulation of mobile element activity most likely had a profound effect on genome evolution in D.
discoideum.
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Transposable elements are found in virtually all organisms
and play central roles in shaping their host’s genomes. The
amplification of these genomic parasites is a constant
threat to host fitness due to the intrinsic process of inte-
gration into the genomic DNA that can cause mutagenesis
of genes and force illegitimate recombinations between
distant transposon copies [1–4]. Eukaryotic cells have
evolved several pathways of RNA interference (RNAi) to
restrain the amplification of transposons at the posttran-
scriptional level [5–8]. In this process, long RNA duplexes
(dsRNA), which may occur in cells as intermediates of
transposon or RNA virus replication, are typically proc-
essed into 20–30 nucleotide double-stranded small inter-
fering RNAs (siRNAs) by ribonuclease III-type enzymes
such as Dicer. The siRNAs are loaded onto RNA-induced
silencing complexes (RISCs), which are minimally com-
posed of an Argonaute protein and a small RNA [9, 10].
Argonaute proteins are characterized by an RNA-binding
PAZ (Piwi-Argonaut-Zwille) domain and a catalytic, ribo-
nuclease H-like PIWI (P-element-induced wimpy testis)
domain. Argonaute proteins bind siRNAs via their PAZ
domains, unwind the siRNA duplex and use one of the
single-stranded RNA molecules as guides to bind mRNAs
in a sequence-specific manner [9]. If the guide RNA is
fully complementary to the target RNA across the active
site of the Argonaute protein, the enzyme is able to de-
grade the target RNA by a single endonucleolytic cut exe-
cuted by the PIWI domain, a function termed slicing. If
slicing is precluded by mismatches between the annealing
guide RNA and cellular mRNA, translation is repressed
and mRNA can be degraded by deadenylation and
decapping.
The social amoeba Dictyostelium discoideum has a hap-
loid genome in which nearly two thirds of DNA are
protein-coding genes [11]. Despite the remarkable com-
pactness of its genome, D. discoideum accommodates a
large number of mobile elements that add up to approxi-
mately 10 % of the entire genomic DNA [12]. Most likely
for the purpose of suppressing transposition, the organism
has evolved a sophisticated RNAi machinery that includes,
for example, three RNA-dependent RNA polymerases
(RdRPs), two Dicer-like proteins, and five Argonaute-like
proteins [13–17]. Intriguingly, the non-long terminal re-
peat retrotransposon TRE5-A has established a fairly high
amplification rate in growing D. discoideum cells [18, 19]
despite the constitutive production of minus-strand RNA
from an element-internal promoter [20, 21]. Thus, how
TRE5-A manipulates the cellular RNAi machinery to
maintain its remarkable retrotransposition activity is of
interest.
Clearly, D. discoideum cells could take advantage of
TRE5-A’s minus-strand RNA production to downregu-
late TRE5-A plus-strand RNA, the substrate forretrotransposition, using an RNAi pathway. This strategy
is actually realized in the silencing of the tyrosine re-
combinase retrotransposon DIRS-1 in D. discoideum
cells [22]. To suppress TRE5-A amplification, promoter
activity of the C-module, the distinguished minus-strand
RNA promoter at the 3′ end of the TRE5-A element,
could be positively regulated by a host-encoded tran-
scription factor. This could elevate the level of TRE5-A-
derived dsRNA, which could be processed into small RNAs
that guide Argonaute proteins to degrade TRE5-A plus-
strand RNA and prevent retrotransposition. Consistent
with this idea, we previously isolated the C-module-binding
factor (CbfA), a host-encoded DNA-binding protein that
interacts with the C-module of TRE5-A in vitro [23–25].
The gene CbfA-coding could not be inactivated by con-
ventional homologous recombination (knockout) and may
be essential for the growth of D. discoideum cells. We
constructed a knock-in mutant, JH.D, in which the cbfA
gene was replaced by a cbfA variant containing an amber
stop codon at amino acid position 455 [25]. The expres-
sion of an amber suppressor tRNA gene in D. discoideum
cells allows read-through translation without causing an
inherent phenotype [26]. Due to the low efficacy of this
amber suppression, JH.D cells produce less than 5 % of
full-length CbfA protein from the expressed cbfA(amber)
mRNA [25].
JH.D cells have an aberrant developmental phenotype
that can be fully rescued by ectopic expression of CbfA
in the mutant [27]. Transcriptome analyses revealed that
CbfA has general gene regulatory functions in D. discoi-
deum cells [28], making this protein an attractive candidate
as a host protein that could limit TRE5-A expression and
retrotransposition by elevating TRE5-A-derived minus-
strand RNA. Interestingly, we observed that both plus- and
minus-strand RNA of TRE5-A were reduced concurrently
in the CbfA mutant by more than 90 %, and this reduction
of transcript levels was accompanied by a sharp drop in
TRE5-A’s retrotransposition activity in vivo [21]. Remark-
ably, the promoter activity of neither the A-module
(TRE5-A’s plus-strand RNA promoter) nor the C-module
was altered in reporter gene assays in the CbfA mutant
compared to wild-type cells [21]. Thus, we hypothesized
that CbfA supports TRE5-A amplification indirectly by
down-regulating one or several components of the cellular
RNAi machinery. In support of this assumption, a previous
transcriptome analysis revealed an approximately 230-fold
and 3-fold overexpression of the genes encoding D. discoi-
deum Argonaute-like proteins AgnC and AgnE, respect-
ively, in the CbfA-depleted mutant [28].
Here, we found that TRE5-A expression was elevated
in knockout strains of agnC and agnE, suggesting that
CbfA may support the accumulation of TRE5-A tran-
scripts by suppressing an RNAi pathway that involves
these Argonaute proteins. To determine whether control
Fig. 1 Expression of mobile elements in the CbfA underexpressing
mutant JH.D. Expression data are derived from a previous RNA-seq
analysis [28]. RPKM values (reads per kb of mRNA and standardized
to 1 million reads) were obtained for the indicated mobile elements
and calculated as ratio of JH.D versus AX2 and are shown as
“fold change” of expression, meaning that values >1 represent
overexpression of genes in JH.D. Values are means from three
independent cultures ± SD. *p < 0.05, **p < 0.01, ***p < 0.001, relative
to control AX2 cells (Student’s t-test). Black bars indicate non-LTR
retrotransposons, grey bars indicate LTR retrotransposons (including
the tyrosine recombinase retrotransposon DIRS-1), and white bars
indicate putative DNA transposons
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reduction in TRE5-A retrotransposition in vivo, we first
developed a new gene activation (GA) strategy to con-
struct strains that overexpress agnC in the absence of
any residual plasmid sequences inserted in their ge-
nomes. We found that the accumulation of TRE5-A
RNA was reduced in both agnCGA and agnEGA strains.
Next, we employed the previously developed “TRE trap”
retrotransposition assay [18, 19] to determine the retro-
transposition activity of the cellular TRE5-A population
in agnCGA cells. The retrotransposition frequency of the
cellular TRE5-A population was determined to be less
than 10 % of the wild-type level, suggesting that TRE5-A
amplification in D. discoideum cells is under surveillance
of a distinct RNAi pathway that requires AgnC function
and that this control of mobile element expansion is at
least in part overcome by CbfA, a factor derived from
the retrotransposon’s host cell.
Results
CbfA regulates the expression of the Argonaute-like
protein AgnC
Even though the accumulation of TRE5-A RNA in D.
discoideum cells strictly depends on CbfA and this factor
binds to the C-module of TRE5-A in vitro, it does not
regulate the C-module’s promoter activity in vivo [21]. A
probable explanation for this paradox could be that
CbfA exerts an indirect effect by regulating an RNAi
pathway that is involved in the control of TRE5-A ex-
pression. In concordance with a rather indirect and
probably broader function of CbfA in the control of mo-
bile elements, including TRE5-A, the re-evaluation of
previously obtained mRNA-seq data [28] suggested a
considerable amount of deregulation of transposable ele-
ments in the CbfA-depleted mutant JH.D compared to
the parental strain AX2 (Fig. 1). Typically the differential
expression of mobile elements between AX2 and JH.D
cells was highly variable among different cell cultures
and could not be unequivocally verified by quantitative
RT-PCR. Nevertheless, this observation strengthened the
hypothesis that the regulation of steady-state levels of
TRE5-A RNA may not be directly regulated by CbfA by
binding to the C-module, but rather be the result of
CbfA regulating an RNAi pathway involved in the regu-
lation of TRE5-A.
Following this hypothesis we used previously obtained
mRNA-seq data [28] to determine differential expression
of putative RNAi components between the CbfA mutant
JH.D and parent AX2 cells. The Argonaute genes agnC
and agnE were 228-fold and a 2.7-fold, respectively,
overexpressed in JH.D cells (Fig. 2). The genes coding
for Argonaute proteins AgnA and AgnB and the RdRP
RrpC were slightly underexpressed in the JH.D mutant
cells, whereas expression of the genes coding for theRdRPs rrpA and rrpB were unaffected by CbfA depletion
(Fig. 2). RNA-seq also revealed normal expression of the
genes coding for the two Dicer-like proteins of D. discoi-
deum, drnA and drnB, in the CbfA mutant (Fig. 2). To
confirm the RNA-seq data, we determined the expression
the Dicer genes, the three RdRPs, and the five Argonaute
genes by qRT-PCR. For these measurements we combined
three RNA samples used in the previous RNA-seq experi-
ment with RNA preparations from three additional inde-
pendent cultures. The data were consistent in all six
biological replicates and are presented in Fig. 2. The strong
overexpression of agnC in the CbfA mutant was confirmed
(257-fold, p < 0.01, Student’s t-test). The weak overexpres-
sion of agnE seen in RNA-seq could not be verified by
qRT-PCR at a statistically significant level (4.3-fold overex-
pression; p = 0.17), although the trend to agnE overexpres-
sion in JH.D was reproduced (Fig. 2). The weak but highly
significant underexpression of agnA in the JH.D mutant
observed by RNA-seq (2.1-fold; p < 0.001) was confirmed
by qRT-PCR (3.6-fold; p < 0.01), whereas results for agnB
were inconclusive (Fig. 2).
CbfA can be divided into an amino-terminal part con-
taining a “carboxy-terminal jumonji domain” and two zinc
Fig. 2 Expression of RNAi components in CbfA mutant JH.D cells. Expression of Dicer-like proteins (drnA, drnB), RdRPs (rrpA-C) and Argonaute
genes (agnA-E) was analyzed by RNA-seq (gray bars, n = 3) in wild-type AX2 and CbfA-mutant JH.D cells from three independent cultures [28].
These three RNA samples, and RNA from three additional independent cultures, were analyzed by qRT-PCR (black bars, n = 6). Data are shown as
fold change of expression with values >1 meaning that expression in the mutant cells was higher than in the control cells. Values are means ± SD
from three and six independent cultures, respectively. **p < 0.01, ***p < 0.001, relative to wild-type AX2 cells (Student’s t-test)
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(CbfA-CTD) that contains a DNA-binding AT hook motif
(Fig. 3a). We have previously determined that the CbfA-
CTD is able to mediate most of CbfA’s gene-regulatory ac-
tivity without requiring the rest of the CbfA protein [28]
and it also completely restores TRE5-A expression in
JH.D cells [21]. We wanted to evaluate whether the aber-
rant expression of agnC and agnE in JH.D cells was re-
versed by expression of CbfA in the mutant. To this end,
we expressed either full-length CbfA or a GFP fusion to
CbfA-CTD in JH.D cells using multicopy expression plas-
mids as shown in Fig. 3b. To confirm functional expres-
sion of CbfA or CbfA-CTD in JH.D, we first determined
TRE5-A expression (Additional file 1: Figure S1). TRE5-A
underexpression was rescued to wild-type level by full-
length CbfA and was even “over-complemented” by
CbfA-CTD, which was likely due to overexpression of this
protein relative to normal CbfA amounts present in AX2
cells (compare Fig. 3b). The overexpression of agnC in
JH.D was reduced by full-length CbfA by 80 % (p < 0.05)
and by CbfA-CTD by 92 % (p < 0.05) (Fig. 3c). This result
was similar to previous RNA-seq data [28], which revealed
97 % reduction (p < 0.001) of agnC overexpression in re-
sponse to the presence of CbfA-CTD [28]. Taken together,
the data indicate that agnC is a genuine CbfA-regulated
gene that requires CbfA-CTD for proper expression. The
data argued for a role of AgnC in CbfA-dependent TRE5-
A regulation because the accumulation of TRE5-A tran-
scripts is also regulated by CbfA-CTD [21].
Expression of full-length CbfA in JH.D cells had only a
minor effect on the observed overexpression of agnE in
JH.D cells. Likewise, expression of CbfA-CTD in JH.D
cells did not affect agnE overexpression in the CbfA mu-
tant (Additional file 1: Figure S1). The latter results were
consistent with previous RNA-seq data, which did not
indicate an effect of CbfA-CTD on agnE expression [28].
Therefore, we cannot definitely conclude from our data
that agnE is a genuine CbfA-regulated gene.AgnC and AgnE downregulate TRE5-A expression
We performed qRT-PCR measurements to determine
whether putative components of the D. discoideum RNAi
machinery are involved in the silencing of TRE5-A expres-
sion. No significant changes of TRE5-A expression were
determined when the genes coding for the Dicer-like pro-
tein DrnB or the RdRP proteins RrpA and RrpB were
inactivated; however, we detected a mild but significant
underexpression of TRE5-A in rrpC knockout cells (Fig. 4).
Inactivation of agnA or agnB had no effect on TRE5-A ex-
pression (Fig. 4), whereas a 4.3- and 5.9-fold overexpres-
sion of TRE5-A was observed in knockout mutants of
agnC and agnE, respectively (Fig. 4). Overexpression of
TRE5-A in agnC and agnE knockout strains was com-
pletely reversed when AgnC or AgnE was expressed from
a multicopy plasmid in the respective knockout mutant
(Fig. 4), suggesting that both AgnC and AgnE contribute
to TRE5-A regulation.
The role of AgnC and AgnE in the suppression of the
TRE5-A population could be analyzed in more detail if
the corresponding genes would be overexpressed in a
wild-type background, i.e., in a strain with normal CbfA
activity. This was an important consideration because pre-
vious data indicated that CbfA may have functions in
TRE5-A retrotransposition beyond the regulation of
TRE5-A RNA levels in supporting the integration process
upstream of tRNA genes [21]. Usually, overexpression of
proteins in wild-type cells is facilitated by transforming
cells with expression plasmids. We assumed that this
would be a suboptimal strategy for our experiments be-
cause transformants would contain insertions of multi-
copy plasmids at random genomic positions that could
compromise the subsequent determination of retrotran-
sposition activity of the TRE5-A population using the TRE
trap assay (see below). With this consideration in mind,
we decided to generate gene activation (GA) strains in
which the endogenous promoter of either agnC or agnE
was replaced by the strong actin15 promoter (act15P) by
Fig. 3 CbfA controls AgnC expression. a Scheme of the CbfA protein. The 1000-amino acid protein can be roughly divided into an amino-terminal part
that may have chromatin-remodeling activity and a carboxy-terminal part that may facilitate DNA-binding [28, 39]. JmjC: carboxy-terminal jumonji
domain", ZF: zinc finger-like motif; NRD: asparagine-rich domain; CTD: carboxy-terminal domain. The CbfA proteins expressed in mutant JH.D comprised
either the full length protein (amino acids 2–1000) or the CbfA-CTD (amino acids 724–1000). b Expression of CbfA in JH.D cells. CbfA mutant JH.D cells
were transformed with plasmids allowing for the expression of either untagged, full-length CbfA [21] or the GFP-tagged, carboxy-terminal domain of
CbfA (CbfA-CTD) [28]. Shown is a western blot of whole-cell extracts prepared from the indicated strains. CbfA was visualized with the monoclonal
antibody 7 F3 that detects CbfA-CTD. Numbers to the left indicate the sizes of the protein standards in kDa. c Complementation of the agnC
overexpression phenotype in JH.D cells. Expression of agnC in the indicated strains was determined by qRT-PCR. Expression levels in JH.D cells
and JH.D transformants were compared to AX2 wild-type cells and are expressed as “fold change” of expression, meaning that values >1
represent overexpression of genes in the JH.D strains and a value of 1 would indicate complete reversion of the overexpression in JH.D cells.
Values are means from six independent cultures ± SD. **p < 0.01, relative to control AX2 cells (Student’s t-test)
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proach would be that the resulting overexpressor strains
had stable genetic modifications at known genomic loca-
tions with an absence of remaining plasmid sequences, ra-
ther than random (multicopy) plasmid insertions, which
have been shown to generate somewhat aberrant expres-
sion [29].
The agnC locus on chromosome 2 is indicated in
Fig. 5a. The agnC gene shares its upstream sequence
with gene DDB_G0271884, which is transcribed in the
opposite direction. The gene activation construct con-
sisted of a DNA fragment containing a fused actin6/
actin15 promoter element, which allowed for the expres-
sion of a blasticidin resistance gene under the control of
act6P and the agnC gene under the control of act15P in
opposite directions (Fig. 5a). A 1200 bp fragment of the
agnC gene, including its authentic translation start, was
inserted downstream of the act15 promoter, whereasanother 1200 bp fragment covering the complete coding
sequence of gene DDB_G0271884, including 273 bp of
upstream sequence, was cloned downstream of the
blasticidin resistance cassette to generate a classical
two-armed knockout plasmid. After double homolo-
gous recombination in the transformants, 749 bp of up-
stream agnC sequence were replaced by the act15
promoter. PCR on genomic DNA from several inde-
pendent agnCGA mutants confirmed the promoter ex-
change and ensured that the organization at the locus
was otherwise unaffected, particularly with respect to
the upstream gene DDB_G0271884.
Semi-quantitative RT-PCR of agnCGA mutants revealed
strong overexpression of agnC in growing cells, whereas
the transcript was barely detectable in wild-type cells
(Fig. 5b). Whereas a 23-fold overexpression of agnC in JH.D
cells relative to wild-type AX2 cells was determined by
qRT-PCR, AX2[agnCGA] strains contains between 995- to
Fig. 5 TRE5-A expression in agnCGA mutants. a Construction of agnC “gene
nucleotide positions. The gene activation cassette consisted of a hybrid act
BamHI arm contained a 1200 bp DNA fragment covering the complete cod
sequence. The HindIII arm contained 1200 bp of agnC coding sequence, in
of the agnCGA vector with genomic DNA, the expression of agnC was driv
gene DDB_G0271884 was unaffected. b Semi-quantitative RT-PCR analysi
demonstrating overexpression of agnC, normal expression of the neighbo
of TRE5-A (ORF1 and ORF2 sequences). NTC: no template control. c Qua
and three agnCGA mutants. Expression levels were compared to AX2 ce
values <1 represent lower levels of TRE5-A in the mutants relative to w
cultures of the indicated strains ± SD
Fig. 4 Expression of TRE5-A in knockout mutants of RNAi
components. Expression of TRE5-A ORF1 was analyzed by qRT-PCR
in the indicated knockout mutants of Argonaute genes and the
Dicer-like protein DrnB. Phenotype reversion in agnC and agnE
knockouts was accomplished using TAP-tagged agnC and agnE
overexpressed in the respective mutants (agnC−[agnCOE] and
agnE−[ agnEOE]). TRE5-A expression in JH.D cells is shown for
comparison. Expression levels were compared to AX2 wild-type
cells and are expressed as fold change of expression, meaning that
values >1 represent overexpression of genes in the mutants. Data
represent means from three independent cultures ± SD. *p < 0.05,
**p < 0.01 relative to AX2 cells (Student’s t-test)
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the agnCGA mutants had no obvious phenotype during
growth and multicellular development. Expression of the
agnC-upstream gene DDB_G0271884 was not affected by
the homologous recombination yielding the agnCGA
strains (Fig. 5b). Semi-quantitative RT-PCR revealed that
the TRE5-A steady-state transcript level in the agnCGA
mutants dropped sharply and was even more lower than
in JH.D cells (Fig. 5b). This was confirmed by qRT-PCR,
which suggested 24- to 45-fold lower expression of the
TRE5-A ORF1 transcript in agnCGA mutants than in
wild-type cells, compared to a 4-fold decrease seen in
JH.D cells (Fig. 5c). The data suggested that AgnC is dir-
ectly involved in suppressing TRE5-A transcripts in D. dis-
coideum cells.
Strains overexpressing the agnE gene in the AX2
background were constructed by employing the gene
activation strategy as outlined in Additional file 1:
Figure S2. Apparently overexpression of AgnE in the
recovered agnEGA strains resulted in an average of
2.3-fold underexpression of TRE5-A in four strains
tested, thus confirming that AgnE may be involved in
TRE5-A suppression.activation” mutants. The agnC locus on chromosome 2 is indicated by
in6/actin15 promoter (arrows indicate transcription direction). The
ing sequence of gene DDB_G0271884, including 273 bp of upstream
cluding the original translation start site. After double-recombination
en by the act15 promoter, whereas expression of the neighboring
s of RNA from AX2, JH.D, and three independent agnCGA mutants
ring gene DDB_G0271884 and gpdA (loading control), and silencing
ntitative RT-PCR of TRE5-A (ORF1) expression on RNA from JH.D
lls and are expressed as fold change of expression, meaning that
ild-type AX2 cells. Data represent means from four independent
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It seemed plausible that silencing of TRE5-A expression
would diminish retrotransposition of the TRE5-A popu-
lation in the agnC and agnE overexpressor strains. To
directly measure the retrotransposition activity of the
cellular TRE5-A population, we set up a previously
described “TRE trap” in vivo retrotransposition assay
[18, 19] in agnCGA cells. The TRE trap is based on a
modified pyr56 gene (TREtrap) that codes for UMP
synthase (Fig. 6). The TREtrap gene contains an intron
into which a ValUAC tRNA gene was inserted as tar-
get for TRE5-A integrations. After transformation of
the TREtrap gene into ura− cells, the transformants
present a ura+ phenotype due to the expression of
functional UMP synthase from the TREtrap gene (with
the intron including the tRNA gene being spliced
out); however, the cells are prone to mutations in the
TREtrap gene by integration of cellular TRE5-A ele-
ments upstream of the embedded tRNA gene. Cells
affected by TRE5-A integration into the TREtrap gene can
no longer splice out the intron and are converted to the
ura− phenotype; they can be recovered after clonal
growth in medium complemented with 5-fluorooroticFig. 6 Outline of the TRE trap retrotransposition assay. The TREtrap
gene is a modified version of the pyr56 gene, which codes for the
D. discoideum UMP synthase. The pyr56 gene contains an intron
(dashed line; SD: splice donor site, SA: splice acceptor site) into shich
a tRNA gene is inserted as bait for the integration of TRE5-A. The
TREtrap gene is transformed into the ura− strain DH1 that has a
complete deletion of the pyr56 gene. The TREtrap gene converts
transformants to ura+ because the intron is functionally spliced. If an
element of the endogenous TRE5-A population targets the tRNA
gene in the TREtrap gene for integration, the TREtrap gene is disrupted
even if the integration actually occurs in the intronic sequence. The
resulting ura− cells gain resistance to the drug 5-fluoroorotic acid
(5-FOA) and grow out clonally if uracil is added to the medium [18]acid (5-FOA) and uracil. In previous studies, approxi-
mately 100 insertions into the TRE trap were analyzed
for integration by mobile elements [18, 19]. The data
revealed that ~1 % of recovered ura− clones had spon-
taneous loss-of-function mutations of the TREtrap gene,
whereas ~99 % of the clones carried a TRE5-A element.
No insertions of other members of the tRNA gene-
specific TRE retrotransposon family were detected in
this assay, suggesting that they amplify at a very low
rate. Thus, the number of clones obtained in the TRE
trap assay is an estimate of the TRE5-A retrotransposi-
tion activity in D. discoideum cells [18, 19].
In the experiments described above, AX2 was the
parent strain for the generation of agnCGA and agnEGA
mutants because we wanted to be able to directly com-
pare them to JH.D cells, which were also derived from
AX2. Because no suitable uracil-auxotrophic AX2 mu-
tant was available, we reproduced agnCGA mutants in
the ura− strain DH1, which is an AX3 derivative [30].
As shown in Fig. 7a, overexpression of agnC in the re-
covered DH1[agnCGA] strains was comparable to
AX2[agnCGA] cells. Likewise, TRE5-A ORF1 expression
was suppressed in DH1[agnCGA] strains, albeit at some-
what lower efficacy as in AX2[agnCGA] cells. qRT-PCR
revealed that TRE5-A expression in the particular
DH1[agnCGA] strain that we subsequently used to de-
termine TRE5-A retrotransposition was 7.7-fold lower
than in the parental DH1 strain. This DH1[agnCGA]
strain was transformed with plasmids carrying either
the empty TRE trap (i.e., no tRNA gene inserted in the
trap) or the TREtrap gene, which contained a ValUAC
tRNA gene as bait for TRE5-A integrations. Five plates,
each containing 107 cells, were cultured in minimal
medium supplemented with 5-FOA and uracil until
clones appeared. As the positive control, the TRE5-A
retrotransposition frequency in DH1[TREtrap] cells was
determined at 2.03 × 10−5, whereas it was <0.01 × 10−5 in
DH1[TREtrap] cells in which the ValUAC tRNA gene was
omitted as the negative control. In two independently
recovered DH1[agnCGA/TREtrap] strains, TRE5-A retro-
transposition activity was determined at 0.14 × 10−5 and
0.05 × 10−5, representing a more than 90 % drop retro-
transposition in the agnC overexpressing cells compared
to control cells (p < 0.001, Student’s t-test) (Fig. 7b). These
data indicate that AgnC controls the amplification of
TRE5-A elements in D. discoideum cells by limiting the
accumulation of retrotransposon-derived RNA.
Although we were able to establish agnEGA strains
in the DH1 background, we could not recover viable
cells after transformation of the TREtrap gene into
these cells. Therefore, we were unable to determine
the retrotransposition activity of the TRE5-A popula-
tion under these conditions. Thus, it remains elusive
at this point whether the moderate downregulation of
Fig. 7 Retrotransposition of the TRE5-A population in agnC
overexpressing strains. a Semi-quantitative RT-PCR analysis of RNA
from DH1 and three independent DH1[agnCGA] mutants. Note that
agnC was overexpressed comapred to DH1. Expression of the
neighboring gene DDB_G0271884 (compare Figure 5) was not
affected, whereas expression of TRE5-A ORF1 was reduced in the
agnCGA mutants. Expression of the house-keeping gene gpdA is
shown as control. NTC: no template control. b DH1 and
DH1[agnCGA] cells were transformed with either the empty TREtrap
gene (i.e., no tRNA gene inserted in the intron) or the TREtrap gene
containing a ValUAC tRNA gene. In this TRE trap assay, one clone of
DH1 transformants and two independent clones of DH1[agnCGA] cells
(clones #1 and #2) were analyzed for TRE5-A retrotransposition. For
each strain, five plates containing 107 cells each were prepared. Cells
were cultured in FM medium containing 5-FOA and uracil until clones
appeared. Clones were counted and results are presented as
retrotransposition frequency ± SD. ***p < 0.001 (Student’s t-test). This
assay was reproduced once with similar results
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an appreciable suppression of the retrotransposition
activity of the TRE5-A population.Discussion
AgnC and AgnE act in RNAi pathways to suppress TRE5-A
retrotransposition
Because the TRE5-A element produces both plus- and
minus-strand RNA, we assumed that the retrotransposi-
tion frequency of the TRE5-A population may be under
surveillance by the cellular RNAi machinery. In this
study, we provide evidence to support this assumption.
Genetic inactivation of either AgnC or AgnE resulted in
overexpression of TRE5-A, suggesting that both proteins
have functions in TRE5-A regulation in which the loss
of one cannot be compensated for by expression of the
other. The D. discoideum Argonaute proteins are a part
of the PIWI subfamily of Argonaute proteins. They all
have divergent amino-terminal domains, but possess
conserved PAZ and PIWI domains including an intact
DEDH catalytic tetrad and probably possess slicer activ-
ity. One model to explain TRE5-A silencing is the gener-
ation of PIWI-interacting RNAs (piRNAs) by AgnC and
AgnE in a ping-pong piRNA replication mechanism typ-
ical for PIWI proteins [31]. This model is intuitive given
that piRNAs are often generated from long single-
stranded RNA precursors produced from transposable
elements, such as the minus strand RNA of TRE5-A.
However, piRNA are usually 23–30 nt long [31, 32],
which contradicts results from a previous deep sequen-
cing of small RNA libraries which revealed the forma-
tion of ~21 nt siRNAs from TRE5-A elements at a very
low level (0.05 % of total small RNAs) in growing D. dis-
coideum cells [15].
The silencing of the retrotransposon DIRS-1 is a model
to study RNAi pathways in D. discoideum [14, 15, 17, 22].
Previous deep sequencing of small RNAs revealed high
levels of DIRS-1-derived ~21 nt siRNAs [15] that add up
to 20 % of all small RNAs detected in D. discoideum cells
[17]. The difference in the amount of ~21 nt siRNAs de-
rived from DIRS-1 and TRE5-A may be interpreted as the
less efficient dsRNA formation from TRE5-A RNA com-
pared to DIRS-1 RNA. DIRS-1 silencing is enhanced by
the RdRP RrpC that synthesizes new DIRS-1 dsRNA that
can be diced into secondary siRNAs [16]. This amplifica-
tion step may be missing in the RNAi pathway that con-
trols TRE5-A expression, because TRE5-A transcripts
were not stabilized in RdRP-deficient mutants. The Dicer
homolog DrnB, which is mainly required for miRNA for-
mation in D. discoideum [15], is apparently not involved
in the regulation of DIRS-1 RNA levels [17] and it seems
to be also dispensable in the process of TRE5-A regulation
(Fig. 4). Thus, the RNAi pathways that regulate DIRS-1
and TRE5-A may overlap at the stage of primary siRNA
formation, presumably involving the Dicer homolog
DrnA, but use different RISCs that contain either AgnA
for DIRS-1 silencing [22] or AgnC/AgnE for TRE5-A
suppression.
Schmith et al. Mobile DNA  (2015) 6:14 Page 9 of 12CbfA abrogates TRE5-A suppression by repressing AgnC
The C-module at the 3′ end of the TRE5-A element has
promoter activity that is responsible for the production
of minus-strand RNA by the element [20]. CbfA was ori-
ginally identified as a “C-module-binding factor” because
it binds to the C-module of TRE5-A in vitro [24], but it
does not regulate the C-module promoter activity
in vivo [21]. Considering that CbfA regulates more than
1000 genes of the D. discoideum genome, the present
data suggest that the observations of in vitro binding of
CbfA to the C-module and in vivo regulation of steady-
state levels of TRE5-A transcripts by CbfA are purely
coincidental. Together with the data obtained in this
study, we propose instead that the accumulation of
TRE5-A transcripts in D. discoideum cells is indirect
and a result of the CbfA-mediated suppression of a post-
transcriptional pathway involving AgnC. This assumption
is supported by the observation that both the plus- and
minus-strand RNA of TRE5-A simultaneously vanish
upon removal of CbfA from cells, but reappear when
CbfA is re-introduced into CbfA-underexpressing cells
[21]. In a previous mRNA-seq experiment comparing
gene expression in JH.D with wild-type cells [28] we de-
tected underexpression of putative DNA transposons
such as DDT-A and DDT-S, the long-terminal repeat
(LTR) retrotransposon Skipper, and the non-LTR retro-
ransposon TRE5-B (see Fig. 1). RNA-seq also predicted
overexpression of some mobile elements in the absence
of CbfA such as the tyrosine recombinase retrotrans-
poson DIRS-1, the LTR retrotransposon DGLT-A, and
the non-LTR retrotransposons TRE3-C and TRE3-D.
However, differential expression of the mentioned mo-
bile elements in JH.D cells could not be unequivocally
confirmed by qRT-PCR. This was obviously due to high
biological variation between independent cultures that
was never observed when analyzing the expression of cod-
ing genes (i.e., Fig. 2) and the reason for this phenomenon
remains elusive. At least the overexpression of DIRS-1 in
JH.D cells could be explained by the weak, but reprodu-
cible overexpression of the genes rrpC and agnA (Fig. 2),
which were both shown to be involved in the downregula-
tion of DIRS-1 [22]. Thus, DIRS-1 and TRE5-A may be
suppressed by different RNAi pathways and are affected
indirectly by CbfA’s broad-ranging gene-regulatory activ-
ity. Unfortunately, a high variability of mobile element ex-
pression among biological replicates was also observed
when analyzing either agnC knockout or agnC overex-
pressor cells. Therefore, we are unable at this point to pre-
dict whether other mobile elements are regulated by the
same AgnC-involving RNAi pathway that controls TRE5-
A retrotransposition.
TRE5-A belongs to a family comprising seven tRNA
gene-targeting retrotransposons in D. discoideum cells.
The TRE5-A and TRE5-B elements are closely relatedand share a common ancestor, but only TRE5-A was
amplified to a high copy number rather late in the evolu-
tion of this species [12]. It is puzzling that TRE5-A amp-
lification in D. discoideum was apparently accelerated
after the acquisition of the C-module (i.e., an antisense
promoter) and after the split from its common ancestor
with the TRE5-B element that lacks a C-module. Intui-
tively, the incorporation of an antisense promoter into a
mobile element should make it vulnerable to silencing
by RNAi-related mechanisms and thus prevent its amp-
lification. Because the C-module was most likely ac-
quired by 3′-transduction, a process not uncommon in
this class of retrotransposons [33], the question of what
advantage the element may have gained by incorporating
an antisense promoter at its 3′ end remains. Did D. dis-
coideum cells gain a selective advantage from TRE5-A
expansion? The release of TRE5-A from RNAi surveil-
lance by a regulated process involving a host-encoded
factor such as CbfA may have evolved because it could
be used for cellular purposes such as enhancing genome
flexibility. Alternatively, TRE5-A release from suppres-
sion by RNAi may have been incidentally caused by
adaptation to evolutionary pressure forcing alterations in
AgnC-mediated posttranscriptional regulation that are
unrelated to transposon suppression. It is unknown
under which conditions the repression of agnC by CbfA
would be released or for which functions AgnC would
be required; at least, it seems to be unrelated to the
multicellular development of D. discoideum because
agnC is barely upregulated during development [34] and
neither agnC knockouts nor agnC overexpressor display a
developmental phenotype. Repression of AgnC by CbfA
may provide an efficient way to respond to changes in par-
ticular environmental conditions that require specialized
functions of this Argonaute protein. Even if this mode of
gene regulation by CbfA would come at the cost of TRE5-
A amplification, it is reasonably tolerable because TRE5-
A’s targeted integration to regions upstream of tRNA
genes would largely prevent insertion mutagenesis of the
genome.
Whereas RNAi may have been developed to restrict
mobile element expansion in D. discoideum as in other
eukaryotes, as exemplified by DIRS-1 silencing, our
study shows an intriguing example of a transposable
element that is under surveillance by the cellular RNAi
machinery, but the control of which can be overcome by
suppression of a distinct RNAi pathway by a host factor.
Conclusions
The social amoeba D. discoideum has a compact and
haploid genome that requires tight control of mobile
element activity to maintain genome stability. The non-
long terminal repeat retrotransposon TRE5-A actively
amplifies in the genome of D. discoideum even though
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silencing due to the production of antisense RNA from
an element-internal promoter. The host-encoded factor
CbfA has global gene-regulatory functions in D. discoi-
deum that include the suppression of the Argonaute-like
proteins AgnC and AgnE. Whereas TRE5-A transcipts
were found to accumulate in mutants lacking AgnC or
AgnE, expression and retrotransposition of the element
vanished in AgnC and AgnE overexpressing cells. These
observations suggest that TRE5-A amplification is under
surveillance by an RNAi pathway that involves AgnC and
AgnE and that this control is at least partially overcome
by the activity of CbfA. This unusual regulation of mobile
element activity by a host factor most likely had a pro-
found effect on genome evolution in D. discoideum.
Methods
Strains and plasmids
The CbfA-depleted mutant JH.D and the plasmids used
for the expression of full-length CbfA and the GFP-
tagged carboxy-terminal domain of CbfA (CbfA-CTD)
have been previously described [21, 25]. D. discoideum
strains harboring knockouts of RdRP genes rrpA, rrpB,
and rrpC were described by Wiegand & Hammann [16].
Knockout strains of agnA and agnB were described else-
where [22]. The drnB− strain was described in Avesson
et al., 2012 [35]. Knockout mutants of agnC and agnE as
well as plasmids allowing for the expression of TAP-
tagged AgnC and AgnE will be described in a separate
publication (F.S. et al., manuscript in preparation).
Construction of gene activation mutants
The D. discoideum expression vector pDM326 [36] con-
tains a blasticidin resistance cassette driven by the act6
promoter and an upstream act15 promoter in opposite
direction for the expression of transgenes. A DNA frag-
ment containing both the blasticidin cassette and the
act15 promoter was isolated from pDM326 by digestion
with BamHI and BglII. The DNA fragment was inserted
into the BamHI site of pGEM7Zf(−) (Promega), such
that the former BglII site was placed next to the HindIII
site of the pGEM vector to generate pGEM-GA. To gen-
erate the agnCGA vector, the “BamHI arm” covering the
entire coding sequence of the gene DDB_G0271884,
which shares its upstream region with agnC, was ampli-
fied including 273 bp of residual upstream sequence
and inserted into the BamHI site of pGEM-GA. The
“HindIII arm” was generated by amplification of nucle-
otides 1–1166 of the agnC gene including its authentic
translation start codon. The pGEM-agnC-GA plasmid
was linearized and transformed into D. discoideum
AX2 or DH1 cells and transformants were selected in
HL5 medium (Formedium, Hunstanton, UK) contain-
ing 6 μg/ml blasticidin (Life Technologies, Carlsbad,USA) [37]. From such clones genomic DNA was iso-
lated and screened by PCR for insertion of the GA cas-
sette at the targeted locus using one primer specific for
the blasticidin resistance gene and a second primer that
hybridized outside of the DNA sequences covered by
the HindIII arm. RT-PCR was used to confirm that the
expression of the agnC-upstream gene DDB_G0271884
was not affected by insertion of the GA cassette.
Reverse transcription-PCR
Total RNA was prepared from frozen cell pellets and
RT-PCR was done as described previously [21]. In
quantitative RT-PCR gene expression levels were stan-
dardized to the gene coding for catalase (catA). The fol-




















GGTTGAATCATATTTGAAC; TRE5-A ORF1 Rep-108,
GTCATAAACATCAATCCGAACCAGAC; TRE5-A ORF1
Rep-109, GTTAGATTGTCTAGTTCAATGATAGTGTC;
TRE5-A ORF2 Rep-75, GACTGTTCAGTGGATAATAA




TRE trap retrotransposition assay
The TRE trap is an in vivo retrotransposition assay that
measures the activity of the cellular TRE5-A population.
It was essentially performed as described previously [21].
The TRE trap consists of the complete pyr56 gene modi-
fied to contain a functional intron into which a ValUAC
bait tRNA gene was inserted. This gene is referred to as
the TREtrap gene. After transformation into D. discoideum
DH1 cells, ura+ cells harboring chromosomal integrations
of the TREtrap gene were recovered by cultivation in FM
medium without supplements. After integration of a
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rupted and no functional UMP synthase is expressed.
Thus, affected cells were converted to the ura− phenotype
and gained resistance to the drug 5-fluoroorotic acid
(5-FOA). In a typical retrotransposition assay, 5 plates
each containing 107 cells were prepared, and cells were
cultured in FM medium containing 150 μg/ml 5-FOA and
20 μg/ml uracil. Clones that arose were counted, and the
data presented are the means from 5 plates ± SD.
Western blots
D. discoideum cells were washed in phosphate buffer and
stored as frozen pellets of 2 × 107 cells at −80 °C. SDS/
polyacrylamide gel electrophoresis of whole-cell extract
proteins and western blotting were done as described
[38]. We used monoclonal antibody 7 F3 to detect CbfA
and a polyclonal antiserum to detect actin8 [38].
Additional data files
The following additional data are available with the online
version of this paper. Additional file 1: Figure S1 shows
the functional complementation of strain JH.D with CbfA
or its carboxy-terminal domain with respect to TRE5-A
and agnE expression. Additional file 1: Figure S2 illustrates
the construction of agnEGA mutants and shows the ex-
pression of TRE5-A in these mutants.Additional file
Additional file 1: Figure S1. Functional complementation of strain
JH.D with CbfA or its isolated carboxy-terminal domain. RNA levels of
retrotransposon TRE5-A (A) and agnE (B) were determined by qRT-PCR in JH.D
cells, JH.D cells expressing full-length CbfA, and JH.D cells expressing CbfA-CTD.
Expression levels in JH.D cells and JH.D transformants were compared to AX2
wild-type cells and are expressed as “fold change” of expression, meaning
that values >1 represent overexpression of genes in the JH.D strains and a
value of 1 would indicate complete reversion of the overexpression in JH.D
cells. Values are means from six independent cultures ± SD. **p < 0.01,
relative to control AX2 cells (Student’s t-test). Note that TRE5-A is actually
overexpressed in the JH.D[CbfA-CTD] transformant, which is an effect of
overexpression of CbfA-CTD (see Fig. 2, main text). Figure S2. TRE5-A
expression in agnEGA mutants. (A) Construction of agnE “gene activation”
mutants. The agnE locus on chromosome 5 is indicated by nucleotide
positions. The gene activation cassette consisted of a hybrid actin6/actin15
promoter (arrows indicate transcription direction). The BamHI arm contained
a 1070 bp DNA fragment covering part of the coding sequence of
gene DDB_G0289385. The HindIII arm contained 1080 bp of agnE
coding sequence, including the original translation start site. After
double-recombination of the agnEGA vector with genomic DNA, the
expression of agnE was driven by the act15 promoter, whereas expression of
the neighboring gene DDB_G0289385 was unaffected. (B) Semi-quantitative
RT-PCR analysis of RNA from AX2, JH.D, and three independent agnEGA
mutants demonstrating overexpression of agnE, normal expression of the
neighboring gene DDB_G0289385 and gpdA (loading control), and silencing
of TRE5-A (ORF1 and ORF2 sequences). NTC: no template control. (C)
Quantitative RT-PCR of TRE5-A (ORF1) expression on RNA from JH.D and
four agnEGA mutants. Expression levels were compared to AX2 cells and are
expressed as fold change of expression, meaning that values <1 represent
lower levels of TRE5-A in the mutants relative to wild-type AX2 cells.
Data represent means from four independent cultures of the indicated
strains ± SD. (PDF 1033 kb)Abbreviations
CbfA: C-module-binding factor; CTD: carboxy-terminal domain (of CbfA);
GA: gene activation (by promoter swapping); LTR: long terminal repeat;
qRT-PCR: quantitative reverse-transcription PCR; RdRP: RNA-dependent RNA
polymerase; RISC: RNA-induced silencing complex; RNAi: RNA interference;
siRNA: small interfering RNA; TAP: tandem affinity purification; TRE5-A: tRNA
gene-targeted retroelement 5-A.
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